Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59

References

• Barac-Latas V, Suchanek G, Breitschopf H, Stuehler A, Wege H, Lassmann H (1997). Patterns of oligodendro - cyte pathology in coronavirus-induced subacute de-myelinating encephalomyelitis in the Lewis rat. Glia 19: 1–12.
   Google Scholar
• Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL (1984). Murine hepatitis virus-4 (strain JHM)-induced neu-rologic disease is modulated in vivo by monoclonal antibody. Virology 132: 261–270.
   PubMed Web of Science ®Google Scholar
• Circolo A, Gautier G, Fukuda W, Wang X, Hidvegi T, Szalai AJ, Briles DE, Volanakis JE, Wetsel RA, Colten HR (1999). Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahe-patic expression of C3 mRNA. Immunopharmacology 42: 135–149.
   PubMed Web of Science ®Google Scholar
• Das Sarma J, Fu L, Tsai JC, Weiss SR, Lavi E (2000). Demyeli-nation determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. I Virol 74: 9206–9213.
   PubMed Web of Science ®Google Scholar
• Fleming JO, Wang Fl, Trousdale MD, Hinton DR, Stohlman SA (1993). Interaction of immune and central nervous systems: contribution of anti-viral Thy-1+ cells to de-myelination induced by coronavirus JHM. Reg Immunol 5: 37–43.
   Google Scholar
• Gombold JL, Sutherland RM, Lavi E, Paterson Y, Weiss SR (1995). Mouse hepatitis virus A59-induced demyelina-tion in mice can occur in the absence of CD8+ T cells. Microb Pathogen 18: 211–221.
   Google Scholar
• Herndon RM, Price DL, Weiner LP (1977). Regeneration of oligodendroglia during recovery from demyelinating disease. Science 195: 693–694.
   PubMedGoogle Scholar
• Houtman JJ, Fleming JO (1996). Dissociation of demyeli-nation and viral clearance in congenitally immuno-deficient mice infected with murine coronavirus JHM. J NeuroVirol 2: 101–110.
   Web of Science ®Google Scholar
• Jordan CA, Friedrich VL Jr, Godfraind C, Cardellechio CB, Holmes KV, Dubois-Dalcq M (1989). Expression of viral and myelin gene transcripts in a murine CNS demyeli-nating disease caused by a coronavirus. Glia 2: 318–329.
   Google Scholar
• Lampert PW, Sims JK, Kniazeff AJ (1973). Mechanism of demyelination in JHM virus encephalomyelitis. Elec-tron microscopic studies. Acta Neuropathol (Berl) 24: 76–85.
   Google Scholar
• Lavi E, Gilden DH, Wroblewska Z, Rorke LB, Weiss SR (1984a). Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 34: 597–603.
   PubMedGoogle Scholar
• Lavi E, Gilden DH, Highkin MK, Weiss SR (1984b). Persis-tence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. I Virol 51: 563–566.
   Google Scholar
• Linington C, Lassmann H (1987). Antibody responses in chronic relapsing experimental allergic encepha-lomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte gly-coprotein (MOG). J Neuroimmunol 17: 61–69.
   PubMedGoogle Scholar
• Linington C, Morgan BP, Scolding NJ, Wilkins P, Piddlesden S, Compston DA (1989). The role of complement in the pathogenesis of experimental allergic encephalomyeli-tis. Brain 112: 895–911.
   Google Scholar
• Litzenburger T, Fassler R, Bauer J, Lassmann H, Linington C, Wekerle H, Iglesias A (1998). B lymphocytes pro-ducing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med 188: 169–180.
   PubMedGoogle Scholar
• Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000). Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination [see comments]. Ann Neurol 47: 707–717.
   PubMed Web of Science ®Google Scholar
• Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H (1996). Distinct patterns of multiple sclerosis pathology indi-cates heterogeneity on pathogenesis. Brain Pathol 6: 259–274.
   PubMed Web of Science ®Google Scholar
• Mastaglia FL, Carroll WM, Jennings AR (1989). Spinal cord lesions induced by antigalactocerebroside serum. Clin Exp Neurol 26: 33–44.
   Google Scholar
• Matthews AE, Weiss SR, Shlomchik M, Hannum LG, Gombold J, Paterson Y (2001). Antibody is required for clearance of infectious murine hepatitis virus A59 from the CNS but not the liver. I Immunol 167: 5254–5263.
   Google Scholar
• Miller DJ, Bright JJ, Sriram S, Rodriguez M (1997). Suc-cessful treatment of established relapsing experimen-tal autoimmune encephalomyelitis in mice with a monoclonal natural autoantibody. I Neuroimmunol 75: 204–209.
   Google Scholar
• Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M (1994). Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 14: 6230–6238.
   Google Scholar
• Ozawa K, Saida T, Saida K, Nishitani H, Kameyama M (1989). In vivo CNS demyelination mediated by anti-galactocerebroside antibody. Acta Neuropathol 77: 621–628.
   Google Scholar
• Pavelko KD, van Engelen BG, Rodriguez M (1998). Accel-eration in the rate of CNS remyelination in lys olecithin-induce d demyelination. J Neurosci 18: 2498–2505.
   PubMed Web of Science ®Google Scholar
• Piddlesden SJ, Lassmann H, Zimprich F, Morgan BP, Linington C (1993). The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is re-lated to their ability to fix complement. Am J Pathol 143: 555–564.
   PubMed Web of Science ®Google Scholar
• Rodriguez M (1991). Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells. Lab Invest 64: 358–370.
   PubMed Web of Science ®Google Scholar
• Schluesener HJ, Sobel RA, Linington C, Weiner HL (1987). A monoclonal antibody against a myelin oligoden-drocyte glycoprotein induces relapses and demyelina-tion in central nervous system autoimmune disease. J Immunol 139: 4016–4021.
   PubMedGoogle Scholar
• Sutherland RM, Chua MM, Lavi E, Weiss SR, Paterson Y (1997). CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating dis-ease. J NeuroVirol 3: 225–228.
   Web of Science ®Google Scholar
• Talbot PJ, Buchmeier MJ (1987). Catabolism of homologous murine monoclonal hybridoma IgG antibodies in mice. Immunology 60: 485–489.
   PubMedGoogle Scholar
• Van der Goes A, Kortekaas M, Hoekstra K, Dijkstra CD, Amor S (1999). The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages. I Neu-roimmunol 101: 61–67.
   Google Scholar
• van Engelen BG, Miller DJ, Pavelko KD, Hommes OR, Rodriguez M (1994). Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis. I Neurol Neu-rosurg Psych 57 (Suppl): 65–68.
   Google Scholar
• Wang Fl, Stohlman SA, Fleming JO (1990). Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. I Neuroimmunol 30: 31–41.
   Google Scholar
• Wu GF, Dandekar AA, Pewe L, Perlman S (2000). CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. Jimmunol 165: 2278–2286.
   PubMed Web of Science ®Google Scholar
• Wu GF, Perlman S (1999). Macrophage infiltration, but not apoptosis, is correlated with immune-mediated de-myelination following murine infection with a neu-rotropic coronavirus. I Virol 73: 8771–8780.
   Google Scholar
• Xue S, Sun N, Van Rooijen N, Perlman S (1999). Depletion of blood-borne macrophages does not reduce demyeli-nation in mice infected with a neurotropic coronavirus. I Virol 73: 6327–6334.
   Google Scholar